As of Jun 24
| +0.0573 / +5.89%|
The 4 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 3.25, with a high estimate of 12.00 and a low estimate of 1.50. The median estimate represents a +215.53% increase from the last price of 1.03.
The current consensus among 4 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.